The modulation of brain dopamine and GABAA receptors by estradiol: A clue for CNS changes occurring at menopause

Cellular and Molecular Neurobiology

Volumn 16, Issue 2, 1996, Pages 199-212

  Bossé, Roger ^a   Di Paolo, Thérèse ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Dopamine receptors; Entopeduncular nucleus; Estradiol; Frontal cortex; GABAA receptors; Globus pallidus; Nucleus accumbens; Ovariectomy; Striatum; Substantia nigra pars reticulata

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE RECEPTOR; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; ENTOPEDUNCULAR NUCLEUS; FRONTAL CORTEX; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; HORMONAL REGULATION; MENOPAUSE; NONHUMAN; NUCLEUS ACCUMBENS; OVARIECTOMY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTI-ANXIETY AGENTS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; BRAIN CHEMISTRY; DOPAMINE; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; ESTRADIOL; FEMALE; FLUNITRAZEPAM; GLOBUS PALLIDUS; MALE; MENOPAUSE; NEOSTRIATUM; NUCLEUS ACCUMBENS; OVARIECTOMY; OVARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, GABA-A; SCHIZOPHRENIA; SPIPERONE; SUBSTANTIA NIGRA; THALAMIC NUCLEI; TRITIUM;

EID: 0029903205     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088176     Document Type: Article

References (29)

1. Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:366-375.
2. Angermeyer, M. C. (1982). The association between family atmosphere and hospital. Career of schizophrenic patients. Br. J. Psychiat. 141:1-11.
3. Angermeyer, M. C., and Kühn, L. (1988). Gender differences in age at onset of schizophrenia: An overview. Eur. Arch. Psychiatry Neurol. Sci. 237:351-364.
4. Angermeyer, M. C., Goldstein, J. M., and Kühn, L. (1989). Gender differences in schizophrenia: Rehospitalization and community survival. Psychol. Med. 19:365-382.
5. Bardenstein, K. K., and McGlashan, T. H. (1990). Gender differences in affective, schizoaffective, and schizophreniform disorders. A review. Schizo. Res. 3:159-172.
6. Bédard, P. J., and Boucher, R. (1986). Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys. Neurosci. Lett. 64:206-210.
7. A receptor supersensitivity in the internal segment of the globus pallidus following chronic treatment with a D2 agonist (U-91356A) or Levodopa of MPTP-treated monkeys. 17th Annual Meeting of the CCNP, Quebec City, Quebec, Canada, p. 15.
8. 3H]flunitrazepam binding in female rat brain by sex steroid hormones. Eur. J. Pharmacol. 170:95-99.
9. A supramolecular complex. I. Benzodiazepine receptor level changes in some extrahypothalamic brain areas of the female rat following sex steroid treatment. Neuroendocrinology 57:965-973.
10. Childers, S. E., and Harding, C. M. (1990). Gender, premorbid social functioning and long-term outcome in DMS-III schizophrenia. Schiz. Bull. 16:309-318.
11. Crane, G. E., and Naranjo, E. R. (1971). Motor disorders induced by neuroleptics: A proposed new classification. Arch. Gen. Psychiatry 24:179-184.
12. Crossman, A. R. (1990). A hypothesis on the pathological mechanism that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment. Movement Dis. 5:100-108.
13. Davis, K. L., Kahn, R. S., Ko, G., and Davidson, M. (1991). Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiatry 148:1474-1486.
14. Deister, A., and Marneros, A. (1993). Sex-dependent differences in endogenous psychosis. A comparison between schizophrenic, schizo-affective and affective psychoses. Fortsch. Neurol. Psychiatrie 60:407-419.
15. DeLong, M. R. (1990). Primate models of movement disorder of basal ganglia origin. Trends Neurosci. 13:281-285.
16. Diana, M., and Collu, M. (1990). D1 receptors mediated vacuous chewing in the rat: a model of tardive dyskinesia. Pharmacol. Res. 22:45.
17. Di Paolo, T. (1994). Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 5:27-41.
18. Di Paolo, T., Poyet, P., and Labrie, F. (1982). Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sci. 31:2921-2929.
19. Dworkin, R. H. (1990). Patterns of sex differences in negative symptoms and social functioning consistent with separate dimensions of schizophrenic psychopathology. Am. J. Psychiatry 147:347-349.
20. Farde, L., Wiesel, F. A., Nordstrom, A. L., and Sedvall, G. (1989). D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99:828-531.
21. Fibiger, H. C., and Lloyd, K. G. (1984). Neurobiological substrates of tardive dyskinesia: The GABA hypothesis. Trends Neurosci. 7:462-464.
22. Fields, J. Z., Wichlinski, L. J., Ritzmann, R. F., Drucker, G. E., and Gordon, J. H. (1991). Cyclo(leu-glu) reverses the permanent dopamine receptor up-regulation induced by ovariectomy. Drug Dev. Res. 23:261-268.
23. Flor-Henry, P. (1985). Schizophrenia: Sex differences. Can. J. Psychiatry 30:319-322.
24. Gerfen, C. R. (1992). The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15:285-320.
25. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., and Sibley, D. R. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
26. Gerlach, J. (1988). Tardive dyskinesia. Pathophysiological mechanisms and clinical trials. L'Encéphale XIV:227-232.
27. Goldstein, J. M., and Tsuang, M. T. (1990). Gender and schizophrenia: An introduction and synthesis of findings. Schizo. Bull. 16:179-183.
28. Goldstein, J. M., Santangelo, S. L., Simpson, J. C., and Tsuang, M. T. (1990). The role of gender in identifying subtypes of schizophrenia: A latent class analytic approach. Schizo. Bull. 16:263-276.
29. Gomez-Mancilla, B., Boucher, R., Gagnon, C., Di Paolo, T., Markstein, R., and Bédard, P. J. (1993). Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment I. Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors. Move. Disord. 8:144-150.